The former Hospital de la Santa Creu i Sant Pau in the neighborhood of El Guinardó, Barcelona, Catalonia, Spain, is a complex built between 1901 and 1930. It is one of the most prominent works of the Catalan modernisme architect Lluís Domènech i Montaner. The complex was listed as a Conjunto Histórico in 1978.

During the past decade, Hospital de la Santa Cruz y San Pablo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital de la Santa Cruz y San Pablo" are "Acute Coronary Syndrome" (1 trials), "Chest Pain" (1 trials), "Psoriasis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Hospital de la Santa Cruz y San Pablo" in a lesser frequency.

Most popular intervention types in "Hospital de la Santa Cruz y San Pablo" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etanercept" (1 trials), "Fast strategy" (1 trials), "Placebo" (1 trials), "Standard of care strategy" (1 trials) and "etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de la Santa Cruz y San Pablo" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de la Santa Cruz y San Pablo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital de la Santa Cruz y San Pablo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de la Santa Cruz y San Pablo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".